[
    "h3.",
    "A. Oxytocin release from the hypothalamus",
    "Day 1: Isolation of the hypothalamus and OT immunoenzyme assay.",
    "TIMING 2 days.",
    "1.",
    "Anaesthetise an adult male mouse \\(2 months old) with pentobarbitone sodium at a dose of 50 mg/kg.  \r\n  ",
    "2. Turn the whole brain bottom side up after cutting the optic nerve.",
    "Isolate the hypothalamus near the optic chiasma, including the supraoptic and paraventricular nuclei. \r\n  ",
    "4. Place one whole hypothalamus in a 24 multi-well plate with 0.4 ml normal Locke solution on a water bath at 37C. \\(The following experiments were performed at 37C). \r\n  ",
    "CRITICAL STEP #1.",
    "Temperature is very important for successful oxytocin release induced by high potassium.",
    "Therefore, the sample must be kept at 37C for as long as possible during the preparation and experiment.",
    "For example, the bath temperature was set at 37C beforehand.",
    "The solution, pipette tip, Eppendorf tubes and plates were pre-warmed in the water bath or dry incubator at 37C. The centrifuge should be run for 15&#x2013;20 min at 10000 rpm with the temperature control key turned off, when the temperature inside the centrifuge will be 35&#x2013;37C.",
    "5.",
    "Replace the incubation medium 10 times every 5 min.",
    "The hypothalamus tissue was soaked with a total of 6 ml of pre-warmed normal Locke solution at 37C for 50 min and solutions were discarded. \r\n  ",
    "6.",
    "At the 11th, 12th and 13th replacement, reserve aliquots of 0.4 ml of Locke solution \\(after 3-min incubation with the hypothalamus) in 1.5 ml microtubes. \r\n  ",
    "7.",
    "Then, change the incubation liquid to 0.4 ml of 70-mM high-potassium Locke solution and collect 3 min later in a microtube.",
    "PAUSE POINT",
    "Tubes can be stored at &#x2013;80C for measurement of oxytocin concentration for several days just before restarting.",
    "However, it is better to have no pause here.\r\n  ",
    "8.",
    "Make oxytocin standard liquid in tubes 1 through 7 at concentrations of 1000, 500, 250, 125, 62.5, 31.25 and 15.6 pg/ml, respectively.\r\n  ",
    "9.",
    "Pipette 100 microL of standard diluent into the NSB \\(non-specific binding) and B0 \\(0 pg oxytocin/ml standard) wells of a 96-well plate.\r\n  ",
    "10.",
    "Pipette 100 microL of standards 1 through 7 into the appropriate wells.\r\n  ",
    "11.",
    "Pipette 100 microL of the samples \\(from 0.4 ml) into the appropriate wells.\r\n  ",
    "12.",
    "Pipette 50 microL of assay buffer into the NSB wells.\r\n  ",
    "13.",
    "Pipette 50 microL of the blue conjugate into each well, except TA \\(Total activity) and Blank wells.\r\n  ",
    "14.",
    "Pipette 50 microL of the yellow antibody into each well, except the blank, TA and NSB.\r\n  ",
    "15.",
    "Tap the plate gently to mix.",
    "Seal the plate and incubate at 4&#xB0;C for 18&#x2013;24 h. PAUSE POINT \r\n  ",
    "Day 2.",
    "Measurement of optical intensity 2 h.",
    "16.",
    "Empty the contents of the plate and wash by adding 400 microL of wash solution to each well. \r\n  ",
    "17.",
    "Repeat the wash 2 more times for a total of 3 washes.\r\n  ",
    "18.",
    "After the final wash, empty the wells and tap the plate dry on a lint-free paper towel.\r\n  ",
    "19.",
    "Add 5 microL of the blue conjugate to the TA wells.\r\n  ",
    "20.",
    "Add 200 microL of the pNpp \\(p-nitrophenyl phosphate) substrate solution to each well. \r\n  ",
    "21.",
    "Incubate at room temperature for 1 h without shaking.\r\n  ",
    "22.",
    "Add 50 microL of stop solution to each well.",
    "This stops the reaction and the plate should be read immediately.\r\n  ",
    "23.",
    "Read the optical density at 405 nm with a plate reader.\r\n  ",
    "24.",
    "Calculate oxytocin concentration from the standard curve.\r\n  ",
    "25.",
    "High potassium-induced OT release was estimated as the ratio of the OT level in the 70-mM potassium Locke solution over the average OT content in three normal Locke solutions \\(see Fig. 1).\r\n  ",
    "h3.",
    "B. Oxytocin release from nerve endings isolated from the posterior pituitary",
    "Day 1: Isolation of the hypophysis and oxytocin release measurement.",
    "TIMING 2 days.  ",
    "Isolation of nerve endings in the posterior pituitary",
    "1.",
    "Anaesthetise a male mouse with pentobarbitone sodium at a dose of 50 mg/kg.  \r\n  ",
    "2. Remove the whole brain.",
    "Isolate the posterior pituitary.",
    "CRITICAL STEP #2",
    "The mouse posterior pituitary can be found easily as a white-shiny part as compared with the slightly red part of the anterior pituitary gland between the trigeminal nerve trunks running in parallel on the bottom surface of the cranial bone \\(see Fig.",
    "2a-c).\r\n  ",
    "3.",
    "After isolation, incubate the posterior pituitary lobe in 1 ml of normal Locke solution for 1 min. \r\n  4.",
    "Transfer to 1 ml of sucrose solution in a Teflon homogeniser. \r\n  ",
    "5.",
    "Gently homogenise with 5&#x2013;6 stokes. \r\n  ",
    "6. Centrifuge the homogenate in a microtube for 1 min at 100 &#xD7; g.\r\n  7.",
    "The supernatant is then collected. \r\n  ",
    "8.",
    "Centrifuge again for 4 min at 600 &#xD7; g. \r\n  9.",
    "After discarding the supernatant, the pellet is resolved with 200 microL of Locke solution.\r\n  ",
    "10.",
    "Pipette 4&#x2013;5 times with a yellow tip. \r\n  ",
    "11.",
    "Load nerve endings onto cover glasses coated with 0.1% polyornithine in a 35-mm 6-well plate.",
    "CRITICAL STEP #3 The cover glass should be rinsed with 0.1% poly-L-ornithine, for at least 1 h before use, followed by washing at least 3 times with distilled water.",
    "The coated cover glass should be used soon after preparation.\r\n  ",
    "12.",
    "Allow to stand for 5 min to settle. \r\n  ",
    "13.",
    "Discard the floating nerve endings, and wash the wells with 1 ml of Locke solution three times. \r\n  ",
    "14.",
    "Replace 1 ml of Locke solution 10 times every 5 min.\r\n  14.",
    "The following procedure is the same as described for the hypothalamus \\(to Step 5). \r\n  ",
    "h3.",
    "C. OT release induced by extracellular application of cADPR, beta-NAD and cADPcR in the nerve endings.",
    "1.",
    "The mouse hypothalamic nerve endings were prepared as mentioned above. \r\n  ",
    "2.",
    "At the end stage of replacing Locke solution \\(Step #7 in A), incubate the nerve endings with 1 ml of Locke solution with or without 100 microM 8-bromo-cADPR, an antagonist of cADPR, for 60 min. \r\n  3.",
    "Wash the nerve endings quickly three times with 1 ml of Locke solution. \r\n  ",
    "4. Incubate with 1 ml of normal Locke solution with or without 100 microM 8-bromo-cADPR. \r\n  ",
    "5.",
    "Collect the solution incubated for 5 min three times every 5 min for basal oxytocin release. \r\n  ",
    "6.",
    "The preparation is stimulated with 1 ml of normal Locke solution containing 100 microM beta-NAD+, cADPR, cADPcR NAAD, ADPR or 100 nM NAADP with or without 100 microM 8-bromo-cADPR for 5 min."
]